A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany

In Germany, the recently approved 20-valent pneumococcal conjugate vaccine had a substantially higher coverage against pneumonia in adults than the 13-valent vaccine, while the coverage gap compared to the 23-valent polysaccharide vaccine was small https://bit.ly/3q4skov

Detalles Bibliográficos
Autores principales: Bahrs, Christina, Kesselmeier, Miriam, Kolditz, Martin, Ewig, Santiago, Rohde, Gernot, Barten-Neiner, Grit, Rupp, Jan, Witzenrath, Martin, Welte, Tobias, Pletz, Mathias W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812468/
https://www.ncbi.nlm.nih.gov/pubmed/34824055
http://dx.doi.org/10.1183/13993003.02432-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812468/
https://www.ncbi.nlm.nih.gov/pubmed/34824055
http://dx.doi.org/10.1183/13993003.02432-2021

Ejemplares similares